↓ Skip to main content

Dove Medical Press

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma

Overview of attention for article published in OncoTargets and therapy, February 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
9 Mendeley
Title
Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
Published in
OncoTargets and therapy, February 2021
DOI 10.2147/ott.s286274
Pubmed ID
Authors

Chang-shuai Zhou, Ming-tao Feng, Xin Chen, Yang Gao, Lei Chen, Liang-dong Li, De-heng Li, Yi-qun Cao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 11%
Researcher 1 11%
Other 1 11%
Student > Doctoral Student 1 11%
Student > Master 1 11%
Other 0 0%
Unknown 4 44%
Readers by discipline Count As %
Unspecified 1 11%
Environmental Science 1 11%
Biochemistry, Genetics and Molecular Biology 1 11%
Agricultural and Biological Sciences 1 11%
Computer Science 1 11%
Other 1 11%
Unknown 3 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2021.
All research outputs
#20,669,432
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#1,599
of 3,016 outputs
Outputs of similar age
#402,043
of 526,732 outputs
Outputs of similar age from OncoTargets and therapy
#62
of 116 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 526,732 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.